PATENT CLAIM ANALYSIS

Application Number: 15767756
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-10
Patent Classification: ["514", "176000"]

Abstract:
The present invention relates to C-3 novel triterpenone with C-28 urea derivatives of formula (I); or pharmaceutically acceptable salts, pharmaceutically acceptable solvates, pharmaceutically acceptable hydrates, tautomers, stereoisomers, prodrugs, compositions or combination thereof, wherein R 1 , R 2 , R 3 , W, J and X are as defined herein. The present invention also relates to pharmaceutical compositions comprising compounds of formula (I) useful for the treatment of viral diseases and particularly HIV mediated diseases.

Claim (Index 3):
The compound according to  claim 1 , is a compound of the formula (IB): wherein,\n R 1 , R 2 , J and X are same as defined in  claim 1  and \n is substituted or unsubstituted 4-7 membered heterocyclyl; or pharmaceutically acceptable salts, pharmaceutically acceptable solvates, pharmaceutically acceptable hydrates, tautomers, stereoisomers, prodrugs, or combination thereof.

Metadata:
- Claim Count in Document: 20.0
- Percentile: 91.0
- Lexical Diversity: 1.55172
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15549678', '15558677', '12829483', '14758309', '15322581']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.902281732742048
- 35 USC 102 Novelty (BERT): 0.7721400317433158
- Combined Prediction Score: 0.8892675626421748
- Mean Citation Score: 952.640712
- Max Citation Score: 1252.8821
- Similarity Product: 934.2561868209184

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test